Zhang, Li
Mei, Xin
Hu, Zhigang
Yu, Bo
Zhang, Chaoyang
Li, Yong
Liu, Kaitai
Ma, Xuejun
Ma, Jinli
Chen, Xingxing
Meng, Jin
Shi, Wei
Wang, Xiaofang
Mo, Miao
Shao, Zhimin
Zhang, Zhen
Yu, Xiaoli
Guo, Xiaomao
Yang, Zhaozhi
Article History
Received: 16 September 2023
Accepted: 3 January 2024
First Online: 9 January 2024
Declarations
:
: The trial was approved by the fudan university shanghai cancer center ethics committee (2108241-22). The study is registered in ClinicalTrails.gov (NCT04320979). Written informed consent will be obtained from all participants included in the study prior to randomization.
: Not Applicable.
: The authors declare no competing interests.